Literature DB >> 12963901

Factors associated with nonmelanoma skin cancer following renal transplantation in Queensland, Australia.

Helen M Ramsay1, Anthony A Fryer, Carmel M Hawley, Andrew G Smith, David L Nicol, Paul N Harden.   

Abstract

BACKGROUND: Caucasian renal transplant recipients living in Queensland, Australia, have the highest risk of nonmelanoma skin cancer in the world.
OBJECTIVE: To determine clinical and environmental factors associated with posttransplantation nonmelanoma skin cancer in Queensland.
METHODS: 361 Caucasian adult recipients completed a structured interview and full skin examination. Skin cancer details were obtained from hospital records.
RESULTS: Squamous cell carcinoma was strongly associated with blue or hazel eyes, time resident in a hot climate, and pretransplantation squamous cell carcinoma; tumor numbers were associated with birth in a hot climate, childhood sunburn, pretransplantation actinic keratoses, and smoking. The risk of basal cell carcinoma was strongly associated with acute or intermittent sun exposure during childhood and pretransplantation basal cell carcinoma; numbers were associated with blue or hazel eyes, time spent living in a hot climate, and male gender.
CONCLUSION: Clinical and environmental factors can be used to identify recipients at risk of nonmelanoma skin cancer in Queensland.

Entities:  

Mesh:

Year:  2003        PMID: 12963901     DOI: 10.1067/s0190-9622(03)00902-2

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  18 in total

1.  Aggressive Squamous Cell Carcinoma in Organ Transplant Recipients.

Authors:  Joana Lanz; Jan Nico Bouwes Bavinck; Marlies Westhuis; Koen D Quint; Catherine A Harwood; Shaaira Nasir; Vanessa Van-de-Velde; Charlotte M Proby; Carlos Ferrándiz; Roel E Genders; Véronique Del Marmol; Giulia Forchetti; Jürg Hafner; Domenic G Vital; Guenther F L Hofbauer
Journal:  JAMA Dermatol       Date:  2019-01-01       Impact factor: 10.282

Review 2.  Immune profiling and cancer post transplantation.

Authors:  Christopher Martin Hope; Patrick Toby H Coates; Robert Peter Carroll
Journal:  World J Nephrol       Date:  2015-02-06

3.  Timing and Number of Cutaneous Squamous Cell Carcinomas in Transplant Recipients.

Authors:  Charles J Puza; Adela R Cardones; Paul J Mosca
Journal:  JAMA Dermatol       Date:  2018-06-01       Impact factor: 10.282

Review 4.  Malignancy after renal transplantation: the role of immunosuppression.

Authors:  Inés Rama; Josep M Grinyó
Journal:  Nat Rev Nephrol       Date:  2010-09       Impact factor: 28.314

Review 5.  Interventions for actinic keratoses.

Authors:  Aditya K Gupta; Maryse Paquet; Elmer Villanueva; William Brintnell
Journal:  Cochrane Database Syst Rev       Date:  2012-12-12

6.  Smoking and risk of skin cancer: a prospective analysis and a meta-analysis.

Authors:  Fengju Song; Abrar A Qureshi; Xiang Gao; Tricia Li; Jiali Han
Journal:  Int J Epidemiol       Date:  2012-10-11       Impact factor: 7.196

7.  Elevated cutaneous Smad activation associates with enhanced skin tumor susceptibility in organ transplant recipients.

Authors:  Kelly A Harradine; Katie Ridd; Elise F Saunier; Frederic F Clermont; Jesus Perez-Losada; Dan H Moore; Ervin H Epstein; Boris C Bastian; Rosemary J Akhurst
Journal:  Clin Cancer Res       Date:  2009-08-11       Impact factor: 12.531

Review 8.  Immunosuppressive therapy and malignancy in organ transplant recipients: a systematic review.

Authors:  Alex Gutierrez-Dalmau; Josep M Campistol
Journal:  Drugs       Date:  2007       Impact factor: 9.546

9.  Risk of non-melanoma skin cancer in autoimmune hepatitis.

Authors:  John Leung; Lauren Dowling; Isi Obadan; James Davis; Peter A Bonis; Marshall M Kaplan; Darlene Casey; Kathleen Viveiros
Journal:  Dig Dis Sci       Date:  2010-02-18       Impact factor: 3.199

10.  Incidence of malignancy after living kidney transplantation: a multicenter study from iran.

Authors:  Behzad Einollahi; Zohreh Rostami; Mohammad Hossein Nourbala; Mahboob Lessan-Pezeshki; Naser Simforoosh; Eghlim Nemati; Vahid Pourfarziani; Fatemeh Beiraghdar; Mohsen Nafar; Fatemeh Pour-Reza-Gholi; Mitra Mahdavi Mazdeh; Manochehr Amini; Pedram Ahmadpour; Khadijeh Makhdoomi; Ali Ghafari; Mohammad Reza Ardalan; Hamid Taebi Khosroshahi; Farshid Oliaei; Shahrzad Shahidi; Shahin Abbaszadeh; Mohammad Reza Fatahi; Fatemeh Hiedari; Atehieh Makhlogh; Jalal Azmandian; Hamid Reza Samimagham; Heshmatollah Shahbazian; Fatemeh Nazemian; Massih Naghibi; Masoud Khosravi; Ali Monfared; Seyed Majid Mosavi; Javad Ahmadi; Mojgan Jalalzadeh
Journal:  J Cancer       Date:  2012-06-05       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.